Johnson & Johnson to Invest $55 Billion in U.S. Manufacturing and Research Expansion

Johnson & Johnson has announced a major investment of over $55 billion in the United States over the next four years, significantly expanding its manufacturing and research capabilities. The healthcare giant’s latest initiative represents a 25% increase compared to its investments over the previous four-year period.

Major Investment to Boost U.S. Manufacturing Infrastructure

The substantial investment will support the construction of new manufacturing facilities and the expansion of Johnson & Johnson’s research infrastructure across the country. This strategic move reinforces the company’s long-term commitment to enhancing pharmaceutical and medical technology production within the U.S.

As part of the plan, three new manufacturing sites will be built, including a flagship facility in Wilson, North Carolina, where construction officially commenced on Friday.

Expansion of Existing U.S. Facilities

In addition to the new sites, Johnson & Johnson will also expand several of its existing facilities across the United States. The company already operates more manufacturing locations in the U.S. than in any other country, positioning it as a leader in domestic healthcare production and innovation.

This initiative aims to strengthen U.S. healthcare supply chains, increase production capacity, and support advanced medical research and development.

(Sources: investing.com, reuters.com)